SUBJECT ENTRY
Abdomen - 8.g.13.5.1.
Achillodynia - 8.g.13.1.196.
Activity of Bilirubin - 8.g.13.1.40., 8.g.13.6.121.
Acute Bronchiolitis - 8.g.13.3.30.
Acute Coronary Syndrome
- 8.g.13.1.153., 8.g.13.1.154.
Acute Injury of Hydatide
- 8.g.13.2.7.
Acute Myopericardit - 8.g.13.1.163.
Acute Pulpit - 8.g.13.4.8., 8.g.13.4.18., 8.g.13.4.22.
Acute Respiratory
Infections - 8.g.13.3.1.
Adenomatous Polyposis - 8.g.13.2.24.
Aflatoxins and
Aflatoxicoses - 8.g.13.6.13.
Aggressiveness of
Sportsmen - 8.g.13.6.64.
Air Pollution - 8.g.13.6.49.
Alcohol Use Monitoring -
8.g.13.6.24., 8.g.13.6.28.
Alive Organism - 8.g.13.6.60.
Allergic Rhinitis - 8.g.13.1.22., 8.g.13.1.29., 8.g.13.1.152., 8.g.13.1.161., 8.g.13.1.188., 8.g.13.6.10.
Allergy - 8.g.13.1.209.
Alloxan Diabetes - 8.g.13.1.94., 8.g.13.1.100.
Alzheimer’s Disease - 8.g.13.1.52.
Anaerobic-Aerobic
Infections - 8.g.13.1.150.
Analysis of Cannabinoids
- 8.g.13.6.95.
Analysis of Chelidonium
Majus L. - 8.g.13.6.75.
Anemia - 8.g.13.1.122.
Anesthetic Drugs - 8.g.13.2.31.
Ankylosis - 8.g.13.2.50.
Anthrax Infection - 8.g.13.1.4.
Antibiotic Idiosyncrasy
- 8.g.13.2.53.
Antibiotic Therapy - 8.g.13.3.37.
Anticoagulants - 8.g.13.6.124.
Antigens - 8.g.13.1.226.
Antimicrobial Therapy - 8.g.13.1.164.
Antioxidant Capacities
of Georgian Spices - 8.g.13.6.25.
Antioxidant Properties
of Saperavi Oil - 8.g.13.6.132.
Antiphospholipid
Syndrome - 8.g.13.1.79.
Application of Saffron
Extract - 8.g.13.1.46., 8.g.13.1.112.
Arias Syndrome - 8.g.13.3.38.
Arterial
Hypertension - 8.g.13.1.123., 8.g.13.1.156., 8.g.13.1.57., 8.g.13.1.159., 8.g.13.1.173., 8.g.13.1.212., 8.g.13.6.83.
Atherosclerosis
- 8.g.13.1.28., 8.g.13.1.39., 8.g.13.3.48.
Atrial Myxomas - 8.g.13.1.43.
Attention Deficit - 8.g.13.3.12.
Automated Control System
- 8.g.13.1.219.
AV Blockades - 8.g.13.1.3.
Ave-Retrograde
Dissociation - 8.g.13.1.134.
Bacterial Meningitis - 8.g.13.1.60.
Bacterial
Vaginosis - 8.g.13.3.10.
Bacteriophage Therapy - 8.g.13.3.34.
Bandage Materials - 8.g.13.6.98.
Berberin - 8.g.13.1.215.
Biflorac - 8.g.13.3.3.
Bile Duct Injury - 8.g.13.2.30.
Bile Stones - 8.g.13.3.52.
Biocide Activity - 8.g.13.6.56.
Biodefender - 8.g.13.6.65.
Biodegradation - 8.g.13.6.105.
Bioethics - 8.g.13.6.34., 8.g.13.6.61.
Biomedical Research - 8.g.13.6.38.
Biotechnology - 8.g.13.6.54.
Blood - 8.g.13.1.38., 8.g.13.1.56., 8.g.13.1.74., 8.g.13.1.97., 8.g.13.1.115., 8.g.13.1.143., 8.g.13.1.165.
Blood Flow - 8.g.13.1.145.
Blood Group Antigens - 8.g.13.1.223.
Blood Pressure - 8.g.13.1.129., 8.g.13.1.131.
Bone Marrow Aspirate - 8.g.13.3.27.
Bottom Sediments - 8.g.13.6.117.
Brain - 8.g.13.1.11., 8.g.13.1.190.
Brain Insult - 8.g.13.1.86.
Brain Tumours - 8.g.13.1.82.
Breast Cancer - 8.g.13.1.37., 8.g.13.1.83., 8.g.13.1.104., 8.g.13.1.108., 8.g.13.1.136.
Breast Pathologies - 8.g.13.1.148., 8.g.13.5.6.
Bronchial Asthma - 8.g.13.1.204., 8.g.13.1.217., 8.g.13.3.36.
Broncho-Obstructive
Syndrome - 8.g.13.1.30.
Bronchoscopy - 8.g.13.1.41.
Bullous Emphysema - 8.g.13.2.37.
Calcinosis - 8.g.13.5.18.
Camelyn - 8.g.13.1.208.
Cancer of the
Pancreatoduodenal Zone - 8.g.13.1.176.
Cancers - 8.g.13.1.109., 8.g.13.1.136., 8.g.13.1.147.
Capillaroscopy - 8.g.13.5.19.
Carcinoma of Breast - 8.g.13.1.61.
Cardiac Autoantibodies -
8.g.13.1.186.
Cardiohemodynamics - 8.g.13.1.134., 8.g.13.1.138.
Cardiointervalography - 8.g.13.5.19.
Cerebral Insult - 8.g.13.1.5.
Cerebrum - 8.g.13.1.7., 8.g.13.1.32., 8.g.13.1.80., 8.g.13.1.166., 8.g.13.5.13., 8.g.13.5.14., 8.g.13.5.17.
Cervix Uteri Cancer - 8.g.13.1.20.
Cesarean Section - 8.g.13.2.29., 8.g.13.2.38., 8.g.13.5.9.
‘‘Chess’’ Minilaparotomy
- 8.g.13.2.15.
Chiatura Mining Workers
- 8.g.13.6.17.
Child Security - 8.g.13.3.26.
Chlamydial Infection - 8.g.13.1.47., 8.g.13.1.54., 8.g.13.1.55.
Cholelithic Diseases - 8.g.13.1.151.
Chronic Cholecystitis - 8.g.13.1.15., 8.g.13.6.89.
Chronic Heart Failure - 8.g.13.1.9., 8.g.13.1.116., 8.g.13.1.158.
Chronic Lung Diseases - 8.g.13.1.200.
Chronic Maxillary
Sinusitis - 8.g.13.1.185.
Chronic Prostatitis - 8.g.13.1.98., 8.g.13.1.99.
Chronic Rhinitis - 8.g.13.2.16.
Chronic Stress - 8.g.13.1.197.
Chronic Tonsillitis - 8.g.13.1.102.
Cirrhosis - 8.g.13.1.1.
Climacteric Syndrome - 8.g.13.3.45.
Clinical Pharmacology - 8.g.13.3.28.
Coastal Zone - 8.g.13.6.119.
"Comet Tail”
Artefact - 8.g.13.1.195.
Computer Tomography - 8.g.13.5.1., 8.g.13.5.15.
Computer Tomography
Parameters - 8.g.13.5.2.
Congenital Anomalies of
Development - 8.g.13.3.32.
Cor Pulmonary - 8.g.13.1.24., 8.g.13.1.25.
Critical Care - 8.g.13.1.45., 8.g.13.6.67., 8.g.13.6.68.
Crohn’s Disease - 8.g.13.1.180.
Cystic Fibrosis - 8.g.13.1.160.
Cytokines - 8.g.13.1.95.
Cytotoxic Alcaloids - 8.g.13.6.20.
Definition of Androgens
Role - 8.g.13.6.42.
Deformability of
Erythrocytes - 8.g.13.6.36.
Demographic Situation - 8.g.13.6.84.
Demyelination - 8.g.13.4.14.
Dental Implantation - 8.g.13.4.6.
Dental Pulp - 8.g.13.4.25., 8.g.13.4.28., 8.g.13.4.29., 8.g.13.4.33.
Dentate Gyrus - 8.g.13.1.27.
Dentinogenesis - 8.g.13.4.13.
Denture Constructions - 8.g.13.4.30.
Depression - 8.g.13.1.8., 8.g.13.1.87., 8.g.13.1.222., 8.g.13.1.224.
Dermatoses - 8.g.13.1.70.
Development of
Clinical Picture - 8.g.13.1.120.
Diabetes - 8.g.13.1.88., 8.g.13.1.89., 8.g.13.1.132., 8.g.13.1.210.
Diabetes Mellitus - 8.g.13.1.23., 8.g.13.1.112., 8.g.13.1.132., 8.g.13.1.199.
Diabetic Foot - 8.g.13.1.51., 8.g.13.2.32., 8.g.13.6.98., 8.g.13.6.99.
Diagnosis of Carcinoma -
8.g.13.1.107.
Diet - 8.g.13.1.129.
Different Pathology of
Cervix - 8.g.13.1.76.
Digestive System - 8.g.13.1.19., 8.g.13.3.2., 8.g.13.6.3.
Dislipidemia - 8.g.13.1.213.
Dorsal Hippocampus - 8.g.13.1.26., 8.g.13.1.31.
Drug Circulation - 8.g.13.6.14.
Drug Rational Supply - 8.g.13.6.1.
Dysbacteriosis - 8.g.13.1.149.
Ecological Chemical
Mutagens - 8.g.13.6.120.
Embryo Skeleton
Formation - 8.g.13.3.18.
Embryo-toxic Effect of
Nitrogen Compounds - 8.g.13.6.12.
Endometrial Hyperplastic
Processes - 8.g.13.3.43.
Endometrium - 8.g.13.3.10.
Endoscopic Hemostasis - 8.g.13.2.20.
Endotheliocytes - 8.g.13.1.205.
Environmental Factors - 8.g.13.6.116., 8.g.13.6.118.
Epilepsy - 8.g.13.1.49., 8.g.13.1.53., 8.g.13.1.73.
Epileptiform Activity - 8.g.13.1.114.
Erythrocytic Group
Antigens - 8.g.13.6.4.
Esophageal Atresia - 8.g.13.2.48.
Esophagus - 8.g.13.1.63., 8.g.13.2.18.
Fetoplacental
Dysfunction - 8.g.13.3.44.
Fibrobronchoscopy - 8.g.13.2.10.
Fibromyalgia Syndrome - 8.g.13.1.71.
Fluoxetine - 8.g.13.1.198.
Food Additives - 8.g.13.6.113.
Food Colorants - 8.g.13.6.107.
Food-borne Diseases - 8.g.13.6.81.
Functional Indices of
Children - 8.g.13.3.50.
Fungous Diseases - 8.g.13.6.18.
Gastroesophagic Reflux -
8.g.13.3.25.
Gastrointestinal
Bleeding - 8.g.13.2.20.
Gender Differences - 8.g.13.6.5.
Genus Galanthus L. - 8.g.13.6.76.
Georgian Pharmaceutical
Market - 8.g.13.6.7.
Georgian Propolis - 8.g.13.6.85.
Gingivitis Treatment - 8.g.13.3.11.
Global Warming - 8.g.13.6.104.
Glossalgia - 8.g.13.4.5.
Grape Polyphenolic
Compounds - 8.g.13.6.110.
Grape Seed Oil - 8.g.13.6.47., 8.g.13.6.52.
H1N1 Flu Pandemic - 8.g.13.1.225.
Hallux Valgus
Deformation - 8.g.13.2.35.
Halogen and Light
Emitting Diodes - 8.g.13.5.4.
Halogen Containing
Preparations - 8.g.13.1.168., 8.g.13.6.57.
Halothane Anaesthesia - 8.g.13.1.172., 8.g.13.4.3.
Health Maintenance for
Elderly - 8.g.13.6.48.
Health Management System
- 8.g.13.6.114.
Healthcare - 8.g.13.6.53., 8.g.13.6.62., 8.g.13.6.63., 8.g.13.6.92., 8.g.13.6.93., 8.g.13.6.101.
Healthy Nutrition - 8.g.13.6.82.
Heart Deffects - 8.g.13.1.127.
Heart Rhythm - 8.g.13.2.52.
Hemodialysis - 8.g.13.1.191.
Hemorrhagic Colitis - 8.g.13.1.66.
Hemorrhagic Insult - 8.g.13.1.139.
Hemorrhagic Shock - 8.g.13.1.142., 8.g.13.1.181.
Haemorrhoidal Disease - 8.g.13.2.40.
Hepatic Encephalopathy -
8.g.13.1.141., 8.g.13.6.32.
Hepatitis - 8.g.13.1.1., 8.g.13.1.67., 8.g.13.1.69.
Hepatolenticular
Degeneration - 8.g.13.1.17.
Herbal Medicine - 8.g.13.6.59.
Hernia - 8.g.13.2.19.
Hernioplasty - 8.g.13.2.4., 8.g.13.2.9., 8.g.13.2.39., 8.g.13.2.44.
Heroin Addict Patients -
8.g.13.6.102.
Honey Analysis - 8.g.13.6.94.
Human Spinal Cord - 8.g.13.1.105.
Hydrazines and their
Products - 8.g.13.6.131.
Hydronephrosis - 8.g.13.3.23.
Hyperactivity Syndrome -
8.g.13.3.12.
Hypoglycemic Activity - 8.g.13.1.178.
Idiopathic
Thrombocytopenic Purpura - 8.g.13.3.40.
Immune Reactivity - 8.g.13.6.23.
Immune System - 8.g.13.1.44.
Infectious Diseases - 8.g.13.3.21., 8.g.13.3.22., 8.g.13.3.39., 8.g.13.3.41.
Influence of Magnetic
Field - 8.g.13.6.129.
Influence of Natural
Zeolites - 8.g.13.6.50.
Inguinal Hernias - 8.g.13.2.11.
Inherited Thrombophilia
- 8.g.13.3.31.
Intercostal Muscles - 8.g.13.1.106.
Interstitial Cells - 8.g.13.1.33.
Intestine Disbiose
Treatment - 8.g.13.3.3.
Intravenous Intoxication
with Copper Sulfate - 8.g.13.6.130.
Iodine Deficiency - 8.g.13.3.7.
Iron Deficiency Anemia -
8.g.13.1.214., 8.g.13.3.33.
Iron Polyphosphate - 8.g.13.1.220.
Ischemic Heart Diseases
- 8.g.13.1.34., 8.g.13.1.155., 8.g.13.1.78., 8.g.13.1.126., 8.g.13.1.194., 8.g.13.1.201., 8.g.13.1.202.
Ischemic Insult - 8.g.13.1.133.
Keratoconus Treatment - 8.g.13.1.171.
Laparoscopic
Adrenalectomy - 8.g.13.2.1.
Laparoscopic
Cholecystectomy - 8.g.13.2.45.
Laparotomies - 8.g.13.2.46.
Lavallei Dode Stem Bark
- 8.g.13.6.35.
Lead Intoxication - 8.g.13.6.106.
Left-side Hemicolectomy
- 8.g.13.2.33.
Level of Information of
Cancer Patients - 8.g.13.6.2.
Lichen Ruber Plantus - 8.g.13.4.4.
Lithotripsy - 8.g.13.2.21.
Liver - 8.g.13.1.6., 8.g.13.1.81., 8.g.13.1.90., 8.g.13.1.91., 8.g.13.1.92., 8.g.13.1.94., 8.g.13.1.110.
Lung Abscess - 8.g.13.2.10.
Lung Pathologies - 8.g.13.1.119.
Lungs - 8.g.13.1.125.
Malignant Hypertension - 8.g.13.1.173.
Mandible Fractures - 8.g.13.2.51.
Manganese Exposition - 8.g.13.6.87.
Manganese Intoxication - 8.g.13.1.18.
Manganic Encephatolopathy -
8.g.13.1.146.
Marfan Syndrome - 8.g.13.3.29.
Maternal Diabets - 8.g.13.3.17.
Mediastinal Lymph Node Core
Biopsy - 8.g.13.2.13.
Mediastinal Lymphomas - 8.g.13.5.23.
Medical Care - 8.g.13.6.69., 8.g.13.6.80.
Medical cosmetics - 8.g.13.6.109.
Medical Poultices - 8.g.13.6.58.
Melkersson-Rozental
Syndrome - 8.g.13.1.157.
Menopausa - 8.g.13.3.53.
Menopausal Age - 8.g.13.3.16.
Mental Activity in
Children - 8.g.13.5.8.
Mesenteric Neoplasm - 8.g.13.1.169.
Metabolic Syndrome - 8.g.13.1.128.
Mineral Water “Khareshi”
- 8.g.13.6.90.
Mineral Water “Vardzia”
- 8.g.13.1.16.
Mitral Valve Prolapse - 8.g.13.3.35.
Monitoring of Illicit
Drug Use - 8.g.13.6.28.
Monoamines - 8.g.13.1.11.
Myocardial Infarction - 8.g.13.1.42., 8.g.13.1.118.
Myopia - 8.g.13.1.182.
Nature Protection - 8.g.13.6.79.
Neonatal Pneumonia - 8.g.13.3.24.
Neuroleptic Syndrome - 8.g.13.1.137.
Neurospecific Enolase - 8.g.13.3.8.
Newborns - 8.g.13.3.8., 8.g.13.3.14.
Nitric Fertilizers - 8.g.13.3.49.
Nonepileptic Paroxysmal
Disorders - 8.g.13.1.144.
Non-Opioid Analgesic
Microinjections - 8.g.13.1.35.
Non-pharmacological
Treatment for Itching - 8.g.13.1.183.
Nosocomial Infections - 8.g.13.2.17.
Nutrition in Children - 8.g.13.3.51.
Nutrition Ration - 8.g.13.3.13., 8.g.13.3.15.
Nutrition Status - 8.g.13.6.128.
Obturator Hernia - 8.g.13.2.19.
Occupational Diseases - 8.g.13.6.126.
Ocular Pathologies - 8.g.13.1.46.
Old-aged Patients - 8.g.13.1.135.
Oligodendroglial
Intracranial Tumors - 8.g.13.1.229.
Optimization of Venous
Return - 8.g.13.1.91.
Orthodontic
Complications - 8.g.13.4.27.
Orthopedic Methods - 8.g.13.1.221.
Osteoarthrosis - 8.g.13.1.218.
Osteoblasts and Collagen
- 8.g.13.4.37.
Otitis - 8.g.13.1.130., 8.g.13.1.184.
Oxidative Stress - 8.g.13.1.36.
Pain Relief - 8.g.13.6.22.
Pancreatic Cancer
Treatment - 8.g.13.1.103.
Pancreatoduodenectomy - 8.g.13.2.8.
Parodontitis - 8.g.13.4.9., 8.g.13.4.15., 8.g.13.4.16., 8.g.13.4.17., 8.g.13.4.21., 8.g.13.4.26.
Pediatric Care - 8.g.13.6.19.
Pelvis - 8.g.13.1.228.
Percutaneous
Nephrolithotripsy - 8.g.13.2.49.
Perinatal Infections - 8.g.13.3.22.
Period of Being in
Stomach - 8.g.13.3.19.
Periodontium - 8.g.13.4.31., 8.g.13.4.32.
Peripheral Nerve Damage
- 8.g.13.1.75.
Peritonitis - 8.g.13.2.15.
Pesticides - 8.g.13.6.51.
Phage Therapy - 8.g.13.1.93.
Pharmaceutical Market in
Pharmacological Action
of Allium Genus - 8.g.13.1.179.
Pharmacy - 8.g.13.6.14., 8.g.13.6.44., 8.g.13.6.1., 8.g.13.6.7.
Pharyngitis - 8.g.13.4.19.
Phenol-intoxication - 8.g.13.1.96.
Phitodrugs - 8.g.13.6.37.
Physiological
Development of Adolescents - 8.g.13.3.4., 8.g.13.3.6.
Plant Raw Material - 8.g.13.6.108.
Plantar Area Pathologies
- 8.g.13.5.16.
Pneumonia - 8.g.13.1.211.
Pneumonia Alveolitis - 8.g.13.1.48.
Pollution - 8.g.13.6.122., 8.g.13.6.127.
Pollution with Arsenic -
8.g.13.6.121.
Polycystic Kidney - 8.g.13.2.43.
Posttraumatic Stress - 8.g.13.6.29.
Process of Ageing - 8.g.13.6.77.
Production of Medical
Means - 8.g.13.6.11.
Progenitor Precursors’
Committing - 8.g.13.6.66.
Prophylactics of
Gastroduodenitis - 8.g.13.1.16.
Prostate - 8.g.13.1.2.
Prostheses - 8.g.13.4.10., 8.g.13.4.20.
Prosthesis elements - 8.g.13.4.36.
Prosthetic Appliances - 8.g.13.4.24.
Pseudophakic Presbyopia
- 8.g.13.2.42.
Psychogenic Stress - 8.g.13.1.87.
Psychosomatic Diseases - 8.g.13.1.117.
Psychosomatic Pathologies -
8.g.13.1.167.
Psychostimulants - 8.g.13.1.146.
Pulmonary Hypertension -
8.g.13.1.65.
Pulmonary Tuberculosis -
8.g.13.3.20.
Pulmonology - 8.g.13.1.12.
Radioecological
situation - 8.g.13.3.42., 8.g.13.5.3., 8.g.13.5.20., 8.g.13.5.21., 8.g.13.5.22., 8.g.13.6.43., 8.g.13.6.45.
Radionuclides - 8.g.13.5.25.
Rare Diseases for
Rectum Damage - 8.g.13.2.2.
Research of Cardiorhythm
- 8.g.13.1.189.
Rheumatic Carditis - 8.g.13.1.102.
Rheumatoid Arthritis - 8.g.13.1.162., 8.g.13.1.203.
Rhinites - 8.g.13.4.19.
Risk Factors - 8.g.13.6.115.
Salival Glands - 8.g.13.1.124.
Salmonella - 8.g.13.1.207., 8.g.13.6.6., 8.g.13.6.9.
Sarcoidosis - 8.g.13.1.187.
Secretory Otitis - 8.g.13.1.130.
Self-medication - 8.g.13.6.78., 8.g.13.6.123.
Seratonus Effect - 8.g.13.5.7., 8.g.13.5.10.
Sexual Dysfunctions - 8.g.13.1.177.
Sjogren’s Syndrome - 8.g.13.1.206.
Skin Infections - 8.g.13.1.216.
Splenic Rupture - 8.g.13.2.41.
Sportsmen
Cardiorespiratory Systems - 8.g.13.6.33., 8.g.13.6.70.
Stenting - 8.g.13.2.12.
Stomatologic Disease - 8.g.13.4.35.
Study of Antidiabetic
Action - 8.g.13.6.39.
Subconscious Management
- 8.g.13.1.140.
Subutex - 8.g.13.6.73.
Supraventricular
Trioventricular Tachycardia - 8.g.13.1.50.
Sympatectomy - 8.g.13.2.36.
Syndrome of Fear - 8.g.13.1.111.
Syndrome of
Morgan-Edems-Stoks - 8.g.13.1.121.
Systemic
Sarcoidosis - 8.g.13.1.85.
Tantalum Manufacture
Factors in Workers - 8.g.13.6.40.
Technology of Glysocal
Granules - 8.g.13.6.46.
Telegony - 8.g.13.6.72.
Textile Dental Cords - 8.g.13.4.23.
Thermoplastic
Dentures - 8.g.13.4.7.
Thyroid Diseases - 8.g.13.1.58., 8.g.13.1.113., 8.g.13.1.227.
Thyroid Pathologies - 8.g.13.1.77.
Tobacco Smoke Toxic
Components - 8.g.13.6.21., 8.g.13.6.26., 8.g.13.6.30.
Tobacco Smoking - 8.g.13.6.100.
Tooth Hard Tissues - 8.g.13.4.34.
Torch-Infections - 8.g.13.1.21.
Toxic Hepatitis - 8.g.13.1.92.
Tracheal Stenosis - 8.g.13.5.24.
Transnasal Drainage - 8.g.13.2.10.
Transvaginal
Appendectomy - 8.g.13.2.14.
Traumatic Brain Injury -
8.g.13.1.64.
Traumatic Disease - 8.g.13.2.5., 8.g.13.2.6.
Treating Stress Ulcers -
8.g.13.1.193.
Treatment in Elderly - 8.g.13.6.103.
Treatment of Acne Vulgaris
- 8.g.13.1.68.
Treatment of Acute Ulcer
- 8.g.13.5.12.
Treatment of Arthritis -
8.g.13.1.101.
Treatment of Bleeding - 8.g.13.2.3.
Treatment of Cysts - 8.g.13.4.2.
Treatment of Dermatoses
- 8.g.13.6.31.
Treatment of Exudative
Otitis Media - 8.g.13.1.184.
Treatment of Gastric
Lymphoma - 8.g.13.1.170.
Treatment of
Gastroduodenitis - 8.g.13.6.88.
Treatment of Heart
Failure - 8.g.13.1.155.
Treatment of Peptic
Ulcer - 8.g.13.2.28., 8.g.13.2.34.
Treatment of
Periodontitis - 8.g.13.4.1.
Treatment of Stenozis - 8.g.13.2.47.
Treatment of Strabismus
- 8.g.13.1.84., 8.g.13.1.175.
Treatment of Ventricular
Dilatation - 8.g.13.3.9.
Treatment with
Dexamethasone - 8.g.13.6.41.
Tumor Cells - 8.g.13.1.44., 8.g.13.1.108.
Ulcerative Colitis - 8.g.13.1.1., 8.g.13.1.192.
Ultrasound Diagnosis - 8.g.13.5.16.
Ureteral Stone Diseases
- 8.g.13.2.21., 8.g.13.2.22., 8.g.13.2.23., 8.g.13.2.25., 8.g.13.2.26.
Urethrites - 8.g.13.1.174.
Urinary Bladder - 8.g.13.1.62.
Urine Fibromyoma - 8.g.13.3.46.
Use of Plasma Radiations
- 8.g.13.5.5.
Vaginites - 8.g.13.3.47.
Varicella - 8.g.13.1.10.
Varicella-Zoster Virus
Infection - 8.g.13.1.10.
Veneer - 8.g.13.4.11., 8.g.13.4.12.
Ventricular
Extrasystoles - 8.g.13.1.14.
Ventricular Myocardium -
8.g.13.5.11.
Ventricular Tachycardia
- 8.g.13.1.138.
Viral Hepatitis - 8.g.13.1.13., 8.g.13.1.59.
Vitamins - 8.g.13.6.55., 8.g.13.6.71.
Wheezing Symptom - 8.g.13.3.5.
White Flower Onion - 8.g.13.6.16.
Wilson Disease - 8.g.13.1.17.
Working Capasity of
Athletes - 8.g.13.6.27.
Working Conditions - 8.g.13.6.125.
Workplace Conditions - 8.g.13.6.15., 8.g.13.6.74., 8.g.13.6.86., 8.g.13.6.91., 8.g.13.6.96., 8.g.13.6.97.
Wound Healing - 8.g.13.2.27.
Zeolites
- 8.g.13.6.111., 8.g.13.6.112.
β-Blockers - 8.g.13.1.92.
β-Thalassemia - 8.g.13.1.72.